Downingtown, PA, United States of America

M Amin Khan


Average Co-Inventor Count = 3.8

ph-index = 12

Forward Citations = 878(Granted Patents)


Location History:

  • Burlington, MA (US) (1995)
  • Dowingtown, PA (US) (1998)
  • Downington, PA (US) (2000)
  • Dowington, PA (US) (1997 - 2003)
  • Downingtown, PA (US) (1997 - 2004)
  • Carmel, IN (US) (1999 - 2004)

Company Filing History:


Years Active: 1995-2004

Loading Chart...
15 patents (USPTO):Explore Patents

Title: The Innovative Contributions of M Amin Khan

Introduction

M Amin Khan, based in Downingtown, PA, is a prolific inventor with a remarkable portfolio consisting of 15 patents. His contributions primarily focus on the field of controlled release technology, particularly in relation to biologically active compounds. Khan's work is pivotal in enhancing the effectiveness of treatments that require precise delivery of medications.

Latest Patents

Among his latest inventions is the patent for the "Controlled Release of Metal Cation-Stabilized Interferon." This invention addresses a composition and method for the controlled release of interferon, employing a biocompatible polymer to create a stable formulation. The process involves dissolving a polymer in a solvent, dispersing metal cation-stabilized interferon particles into this solution, and solidifying the mixture to form a polymeric matrix that encapsulates the interferon particles.

Another significant patent is focused on the "Modulated Release from Biocompatible Polymers." This invention introduces a composition designed for the controlled release of biologically active agents. The formulation includes a biocompatible polymeric matrix along with a biologically active agent and a metal cation component that regulates the release dynamics. The method involves creating a polymer solution, to which the metal cation and active agent are separately added, ultimately forming a polymeric matrix that ensures effective modulation of the agent's release.

Career Highlights

M Amin Khan has garnered extensive experience through his tenure at notable companies such as Alkermes Controlled Therapeutics, Inc. and Alkermes, Inc. His work at these institutions has allowed him to refine his expertise in drug delivery systems and biocompatible materials, leading to several patented innovations that hold great potential in medical applications.

Collaborations

Throughout his career, Khan has collaborated with fellow professionals such as Howard Bernstein and Mark A Tracy. Their joint efforts likely contributed to his robust patent portfolio and further advancements in the domain of controlled release technologies.

Conclusion

M Amin Khan's innovative inventions have made significant strides in the field of drug delivery and biocompatible compositions. With his extensive patent portfolio and collaborative spirit, he continues to influence the landscape of pharmaceutical technologies, paving the way for advancements that improve patient care and treatment modalities.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…